Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 20, 2021

View Archived Issues

Janssen describes new dihydroorotate dehydrogenase inhibitors

New CDK7 inhibitors discovered at Lilly

Senda Biosciences identifies aryl hydrocarbon receptor antagonists

New three-prime repair exonuclease 1 inhibitors synthesized at Constellation Pharmaceuticals

Axial Therapeutics discovers Toll-like receptor 2 agonists

REST loss promotes breast cancer tumor progression

AcuraStem presents preclinical data for AS-202 in ALS

Novel CD70-directed CAR-NK cells for the treatment of CD70-positive malignancies

Researchers discover more than 1,300 genes linked to congenital heart disease

PFKFB3 targeting shows promise for treating breast cancer

DAN-311 demonstrates consistent and durable efficacy in HER2-low breast cancer models

SRSF1 is a therapeutic target for the treatment of breast cancer

Discovery of T-036, a novel brain-penetrant GCS inhibitor for the treatment of Gaucher's disease

Celularity and Sorrento Therapeutics present preclinical data for CAR19-CYNK immunotherapeutic

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...